Global RNAi for Therapeutic Market By Product Type (siRNA, miRNA) And By End-Users/Application (Cancer, Cardiovascular) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

Abstract Global RNAi for Therapeutic Market is accounted for xx USD million in 2019 and is expected to reach xx USD million by 2026 growing at a CAGR of xx% during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global RNAi for Therapeutic market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. RNAi for Therapeutic Market report covers size, share and forecast (value and volume) by regions, top players, product types and applications, with historical data along with forecast from 2019 to 2026; The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis. By geography, this market has been segregated into five regions with revenue and growth rate of RNAi for Therapeutic from 2013 to 2026, • North America (U.S., Canada, Mexico) • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS) • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific) • Latin America (Brazil, Rest of L.A.) • Middle East And Africa(Turkey, GCC, Rest of Middle East) The major players operating into RNAi for Therapeutic Market include: Alnylam Pharmaceuticals Arbutus Biopharma (Tekmira) Arrowhead Dicerna Pharmaceuticals Mirna Therapeutics Quark Pharmaceuticals RXi Pharmaceuticals Silence Therapeutics Benitec Biopharma miRagen Therapeutics Sylentis Gradalis Sirnaomics Silenseed This report segments the Global RNAi for Therapeutic Market as follows: Global RNAi for Therapeutic Market: Type Segment Analysis siRNA miRNA shRNA Global RNAi for Therapeutic Market: Application Segment Analysis Cancer Cardiovascular HBV Other There are 13 chapters to put on view for RNAi for Therapeutic Market: Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: RNAi for Therapeutic Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 RNAi for Therapeutic Market Overview 1.1.1 RNAi for Therapeutic Product Scope 1.1.2 Market Status and Outlook 1.2 Global RNAi for Therapeutic Market Size and Analysis by Regions (2014-2019) 1.2.1 North America RNAi for Therapeutic Market Status and Outlook 1.2.2 EU RNAi for Therapeutic Market Status and Outlook 1.2.3 Japan RNAi for Therapeutic Market Status and Outlook 1.2.4 China RNAi for Therapeutic Market Status and Outlook 1.2.5 India RNAi for Therapeutic Market Status and Outlook 1.2.6 Southeast Asia RNAi for Therapeutic Market Status and Outlook 1.3 Global RNAi for Therapeutic Market Segment by Types (2014-2025) 1.3.1 Global RNAi for Therapeutic Revenue and Growth Rate Comparison by Types (2014-2025) 1.3.2 Global RNAi for Therapeutic Revenue Market Share by Types in 2018 1.3.3 siRNA 1.3.4 miRNA 1.3.5 shRNA Others 1.4 RNAi for Therapeutic Market by End Users/Application 1.4.1 Global RNAi for Therapeutic Revenue (USD Mn) Comparison by Applications (2014-2025) 1.4.1 Cancer 1.4.2 Cardiovascular 1.4.3 HBV Others Chapter 2 Global RNAi for Therapeutic Competition Analysis by Players 2.1 Global RNAi for Therapeutic Market Size (Million USD) by Players (2014-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 Alnylam Pharmaceuticals 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Alnylam Pharmaceuticals, RNAi for Therapeutic Revenue (Million USD) (2014-2019) 3.1.5 Recent Developments 3.2 Arbutus Biopharma (Tekmira) 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Arbutus Biopharma (Tekmira), RNAi for Therapeutic Revenue (Million USD) (2014-2019) 3.2.5 Recent Developments 3.3 Arrowhead 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Arrowhead, RNAi for Therapeutic Revenue (Million USD) (2014-2019) 3.3.5 Recent Developments 3.4 Dicerna Pharmaceuticals 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Dicerna Pharmaceuticals, RNAi for Therapeutic Revenue (Million USD) (2014-2019) 3.4.5 Recent Developments 3.5 Mirna Therapeutics 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Mirna Therapeutics, RNAi for Therapeutic Revenue (Million USD)(2014-2019) 3.5.5 Recent Developments 3.6 Quark Pharmaceuticals 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Quark Pharmaceuticals, RNAi for Therapeutic Revenue (Million USD)(2014-2019) 3.6.5 Recent Developments 3.7 RXi Pharmaceuticals 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 RXi Pharmaceuticals, RNAi for Therapeutic Revenue (Million USD)(2014-2019) 3.7.5 Recent Developments 3.8 Silence Therapeutics 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Silence Therapeutics, RNAi for Therapeutic Revenue (Million USD) (2014-2019) 3.8.5 Recent Developments 3.9 Benitec Biopharma 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Benitec Biopharma, RNAi for Therapeutic Revenue (Million USD) (2014-2019) 3.9.5 Recent Developments 3.10 miRagen Therapeutics 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 miRagen Therapeutics, RNAi for Therapeutic Revenue (Million USD) (2014-2019) 3.10.5 Recent Developments Chapter 4 Global RNAi for Therapeutic Market Size Type (2014-2019) 4.1 Global RNAi for Therapeutic Market Size by Type (2014-2019) Chapter 5 Global RNAi for Therapeutic Market Size Application (2014-2019) 5.1 Global RNAi for Therapeutic Market Size by Application (2014-2019) 5.2 Potential Application of RNAi for Therapeutic in Future 5.3 Top Consumer / End Users of RNAi for Therapeutic Chapter 6 North America RNAi for Therapeutic Development Status and Outlook 6.1 North America RNAi for Therapeutic Market Size (2014-2019) 6.2 North America RNAi for Therapeutic Market Size by Application (2014-2019) Chapter 7 EU RNAi for Therapeutic Development Status and Outlook 7.1 EU RNAi for Therapeutic Market Size (2014-2019) 7.2 EU RNAi for Therapeutic Market Size by Application (2014-2019) Chapter 8 Japan RNAi for Therapeutic Development Status and Outlook 8.1 Japan RNAi for Therapeutic Market Size (2014-2019) 8.2 Japan RNAi for Therapeutic Market Size by Application (2014-2019) Chapter 9 China RNAi for Therapeutic Development Status and Outlook 9.1 China RNAi for Therapeutic Market Size and Forecast (2014-2019) 9.2 China RNAi for Therapeutic Market Size by Application (2014-2019) Chapter 10 India RNAi for Therapeutic Development Status and Outlook 10.1 India RNAi for Therapeutic Market Size and Forecast (2014-2019) 10.2 India RNAi for Therapeutic Market Size by Application (2014-2019) Chapter 11 Southeast Asia RNAi for Therapeutic Development Status and Outlook 11.1 Southeast Asia RNAi for Therapeutic Market Size and Forecast (2014-2019) 11.2 Southeast Asia RNAi for Therapeutic Market Size by Application (2014-2019) Chapter 12 Market Forecast by Regions and Application (2019-2025) 12.1 Global RNAi for Therapeutic Market Size (Million USD) by Regions (2019-2025) 12.1. North America RNAi for Therapeutic Revenue and Growth Rate (2019-2025) 12.1.2 EU RNAi for Therapeutic Revenue and Growth Rate (2019-2025) 12.1.3 China RNAi for Therapeutic Revenue and Growth Rate (2019-2025) 12.1.4 Japan RNAi for Therapeutic Revenue and Growth Rate (2019-2025) 12.1.5 Southeast Asia RNAi for Therapeutic Revenue and Growth Rate (2019-2025) 12.1.6 India RNAi for Therapeutic Revenue and Growth Rate (2019-2025) 12.2 Global RNAi for Therapeutic Market Size by Application (2019-2025) Chapter 13 RNAi for Therapeutic Market Dynamics 13.1 RNAi for Therapeutic Market Opportunities 13.2 RNAi for Therapeutic Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 RNAi for Therapeutic Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 RNAi for Therapeutic Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
1270

1280

OUR CLIENT